Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) has been given an average rating of “Moderate Buy” by the six research firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company.
Several equities research analysts have recently commented on the company. Stifel Nicolaus assumed coverage on Siemens Healthineers in a research note on Monday, September 18th. They set a “buy” rating for the company. HSBC upgraded Siemens Healthineers from a “hold” rating to a “buy” rating in a research note on Tuesday, September 5th.
Siemens Healthineers Stock Performance
Siemens Healthineers Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
- Five stocks we like better than Siemens Healthineers
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 large caps with red hot RSIs with upside
- What to Know About Investing in Penny Stocks
- Johnson Controls International: Nothing but upside for investors
- How to Calculate Inflation Rate
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.